Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05716893 · ClinicalTrials.gov registry record · Phase 2

Study of Aerobic Training for People Receiving Chemotherapy for Breast Cancer

A Phase 2 study of Breast Cancer and Breast Carcinoma, sponsored by Memorial Sloan Kettering Cancer Center.

Recruiting
Registry status
Phase 2
Development phase
140
Enrollment target
7
Study locations

NCT05716893 is a Phase 2 study of Breast Cancer and Breast Carcinoma that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 140 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The trial reports 7 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05716893, a Phase 2 study of Breast Cancer and Breast Carcinoma, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.

RECRUITING
Registry status
Phase 2
Development phase
140 participants
Enrollment target
7
Study locations

Study Summary

In this study, investigators will compare standard Aerobic Training/AT with adaptive Aerobic Training/AT. Standard AT will be a fixed (unchanging) amount of walking each week, while adaptive AT will adjust the level of exercise depending on participants' response to the exercise. Investigators will see how both study approaches (standard AT and adaptive AT) affect participants' CRF.

Conditions Studied

Breast Cancer Breast Carcinoma

Interventions

  • BEHAVIORAL Adaptive Aerobic Training/AT Dosing
  • BEHAVIORAL Standard (fixed) Aerobic Training/AT dosing

Study Locations (7)

New York

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) - Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities) - Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
  • Memorial Sloan Kettering Nassau (Limited protocol activities) - Rockville Centre

New Jersey

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) - Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) - Middletown
  • Memorial Sloan Kettering Bergen (Limited protocol activities) - Montvale

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2023-01-30
Est. Completion 2028-01-30
Phase Phase 2

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05716893

The ClinicalTrials.gov registry entry for NCT05716893 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Adaptive Aerobic Training/AT Dosing is the first listed.

NCT05716893 reports 7 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.

Frequently Asked Questions

What is clinical trial NCT05716893 about?

NCT05716893 is a clinical study titled "Study of Aerobic Training for People Receiving Chemotherapy for Breast Cancer". In this study, investigators will compare standard Aerobic Training/AT with adaptive Aerobic Training/AT. Standard AT will be a fixed (unchanging) amount of walking each week, while adaptive AT will adjust the level of exercise depending on participants' response to the exercise. Investigators will ...

What is the current status of trial NCT05716893?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 2023-01-30. Estimated completion is 2028-01-30.

What conditions does trial NCT05716893 study?

This clinical trial studies the following conditions: Breast Cancer, Breast Carcinoma.

What interventions are being tested in trial NCT05716893?

The interventions under investigation include: Adaptive Aerobic Training/AT Dosing (BEHAVIORAL), Standard (fixed) Aerobic Training/AT dosing (BEHAVIORAL).

Who is sponsoring clinical trial NCT05716893?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05716893 being conducted?

This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer

All registered trials for this condition

Breast Carcinoma

All registered trials for this condition

New Jersey

All trials with a study site in New Jersey

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.